Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03AZK
|
|||
Drug Name |
Sodium zirconium cyclosilicate
|
|||
Synonyms |
UZSi 9; ZS-9 compound; Sodium zirconium silicate (Na2ZrSi3O9); UZSi-9; CBTCHTJSGLCFMY-UHFFFAOYSA-N; 543686-27-7
Click to Show/Hide
|
|||
Indication | Hyperkalemia [ICD-11: 5C76; ICD-10: E87.5] | Approved | [1] | |
Company |
AstraZeneca
|
|||
Structure |
Download2D MOL |
|||
Formula |
H6Na2O9Si3Zr+2
|
|||
Canonical SMILES |
O[Si]1(O[Si](O[Si](O1)(O)O)(O)O)O.[Na+].[Na+].[Zr]
|
|||
InChI |
1S/2Na.H6O9Si3.Zr/c;;1-10(2)7-11(3,4)9-12(5,6)8-10;/h;;1-6H;/q2*+1;;
|
|||
InChIKey |
CBTCHTJSGLCFMY-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 17141-74-1
|
|||
PubChem Compound ID | ||||
ADReCS Drug ID | BADD_D02521 |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Potassium (K) | Target Info | Binder | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.